A Novel beta-1-6 N-Acetylglucosaminyltransferase, Its Acceptor Molecule, Leukosialin, and a Method for cloning Proteins having Enzymatic Activity
5,629,291; 5,837,813; 5,747,452
Researchers at the University of Michigan we have developed a novel drug delivery application, the ablation of fat tissue by the sustained, localized release of anti-fat drugs. The central premise of this technology is that fat tissue mass can be destroyed by sustained, targeted delivery of drugs af
The Invention Transgenic Kenaf plants (Hibiscus cannabinus L.) have been developed by modifying the endogenous concentration of gibberellins using anti-sense technologies. These novel Kenaf plants have elevated fiber content. Furthermore, the fibers in these plants are of higher quality, substant
The Invention A technology was developed enabling the domestication / commercial husbandry of S neapolitana - The optimal pest control for marine aquaria.The novel technology includes special culture media for propagating the distinct nudibranch life cycle stages, and unique culture apparatus for p
The Invention Plant viruses and viroids exploit plasmodesmata nano-channels as conduits for viral spread. Plasmodesmal proteins, endogenous to plants, have been modified such that they permanently block plasmodesmata nano-channels. This blockage inhibits plant virus spread: a major cause of reduced
A novel genetic system for the elimination of tannins in edible plant materials such as canola seeds and sorghum seeds has been developed. This involves genetic engineering of these plants such that they accumulate a tannin-detoxifying agent. The Need Global agricultural production is greatly infl
The Invention The invention describes a new, reliable and efficient method for mapping and quantifying the contribution of elements to the overall performance of the system they compose.
The Need With the genomic revolution a huge amount of data has become available concerning the expression of
BACKGROUND Research at the University of Manchester has identified a new tissue marker with potential use in the stratification of breast cancer patient groups and improved targeting of treatment for each patient. THE TECHNOLOGY The human homolog of the suppressor of deltex protein (SDRP) is aberran
BACKGROUND The concept of electroluminescent (EL) materials is based on the exposure of an electroluminescent substance to a high frequency electrical field, in contrast to photoluminescence in which a light source is needed to provide stimulation. EL polymer sheets are created using micro-encapsula
Abnormal or unregulated control of the body’s immune system can contribute to a variety of disorders, including but not limited to autoimmune disease and cancer. Standard treatments for autoimmune disease involve administration of non-steroidal anti- inflammatory drugs, corticosteroids, and disease
Background:
Ageing populations coupled with failings in current drug based therapies are driving the quest for new treatments and methods of disease management. One of the most promising advances towards such goals is in the development of regenerative stem cell based therapies. Embryonic stem cell
BACKGROUND A research project in in the Faculty of Life Sciences at the University of Manchester has led to the development of a novel yeast-based drug delivery mechanism. THE TECHNOLOGY A genetically engineered yeast strain, able to express recombinant protein drugs / vaccines and incorporating a g
BACKGROUND Pre-designed self-assembling scaffolds are highly advantageous in a number of areas, including tissue regeneration, 3D cell culture, in vitro toxicity testing and understanding of cell/extracellular matrix interactions. Self-assembling peptides, with the various properties of amino acids
BACKGROUND Enzymes, especially proteases play essential roles in disease specific processes and are valuable targets for therapeutic intervention. A number of methods of targeting enzymes have been used to date. These include specific enzyme inhibitors and polymeric carriers which disintegrate to re
BACKGROUND Conventional fluorescent dyes used in nucleic acid detection methods suffer from a number of limitations. High backgrounds result in false positives and a reduction in sensitivity. The small Stokes shift (difference between excitation and emission wavelengths) often requires optical filte
THE TECHNOLOGY Transgenic zebrafish are becoming increasing important as models for human disease. This organism offers the drug discovery industry a number of advantages including rapid reproductive cycle and large numbers of offspring, ethical preference over other animal models, cost effectivenes
BACKGROUND Ai2 Limited is a University of Manchester spinout company that aims to become a significant player in the global anti-infectives market. The company’s focus is on developing novel anti-microbial products, for out-licensing to healthcare companies across a range of sectors. THE TECHNOLOGY
BACKGROUND There is a high and increasing incidence of allergic disorders such as asthma and hay fever. It is expected that some 300m people in the western world will suffer from allergic diseases by 2010. Upwards of 60% of asthma cases are triggered by allergic responses and up to 1 in 4 urban chil
BACKGROUND Gastrointestinal nematode infections are amongst the commonest infections of man and animals worldwide. Collectively 1 in 3 people on the planet are infected by at least one species and approximately 50% of these are school age children In the developing world they affect the well being o
BACKGROUND Although there is considerable research being carried out in the area of hollow sub-micron constructs for the purposes of encapsulation of useful therapeutic entities, most of the processes developed to date for the preparation of such constructs are incompatible with maintaining the func
BACKGROUND Neuroleptics are the drugs of choice in the treatment of schizophrenia, bipolar mania and related disorders but suffer from troublesome side-effects such as drug induced parkinsonism, restlessness, facial tics etc. The severity and patient acceptability of these effects varies widely. Res
BACKGROUND The increasingly wide spread use of wind generation on power networks imposes a greater requirement for wind-farms to contribute to security of network operation in the same way as conventional generating stations based on synchronous generators. DFIG controllers to date have concentrated
BACKGROUND Neuroleptics are the drugs of choice in the treatment of schizophrenia, bipolar mania and related disorders but suffer from troublesome side-effects such as drug induced parkinsonism, restlessness, facial tics etc. The severity and patient acceptability of these effects varies widely. Res
BACKGROUND The division of Imaging Science and Biomedical Engineering at Manchester has expertise in the statistical analysis of image data. Image analysis is widely employed in sectors such as life sciences, security, defence, biometrics, forensics and medicine. THE TECHNOLOGY A method for modellin
BACKGROUND:
In a culture of rising print costs, high print run wastage rates, and yet rising demand for printed products, often with a need for precision, high definition printing, there is more than ever a need for accurate inspection of the finished product. Compuweb Online Ltd is a Manchester ba
BACKGROUND The majority of everyday clothing consists of textile fibres knitted or woven to produce a fabric. Their primary purpose is structural and aesthetic. Fibres can have added functionality by the integration of electronics into the material from which they are formed. Our vision is to enable
BACKGROUND Biomaterials, either natural or synthetic, can be used to replace tissue, organ or body function for a period of time either for permanent implantation (heart valves), long-term application (contact lenses) or short-lived application (wound-dressings, catheters, etc.). They also have othe
BACKGROUND Knitted gloves are predominantly manufactured using speciality glove-knitting machines, or in certain instances circular-knitting equipment. Seamless gloves are already well-known, but can only be produced with simple plain-knitted structures. In the technical textiles sector, innovation
BACKGROUND Touch and proximity sensing E-Textiles are being developed by a number of research groups. Several methods have been explored including printing electroconductive materials onto a textile substrate, the use of piezoresistive coatings, embroidering electroconductive fibres and attaching wo
BACKGROUND A powerful new platform technology for the production of human collagens is being developed in the Kadler Centre for Cell-Matrix Research within the Department of Life Sciences at the University of Manchester. The collagens most closely mimic human collagen structure, giving a far superio
BACKGROUND In the last 10 years commercial interest in treatment of spinal degeneration in relation to back pain has increased with a large number of devices competing in a market estimated to be worth more than $3.5bn and growing at 15 - 20% pa. This technology being developed at the University of
BACKGROUND Research at the University of Manchester has identified a new tissue marker with potential use in the stratification of breast cancer patient groups and improved targeting of treatment for each patient. THE TECHNOLOGY The human homolog of the suppressor of deltex protein (SDRP) is aberran
BACKGROUND Opticin is a protein present in the eye (in the vitreous humour) and was discovered at University of Manchester by Dr Paul Bishop. Uniquely Opticin has been found to exhibit both cytotoxic AND anti-angiogenic (blood vessel formation) effects on a range of cell lines from different cancers
A new pharmacophore for selective targeting of tumour blood-supply BACKGROUND Cancer is a huge killer, responsible for more than 500,000 deaths in the US and 150,000 in the UK each year, thus making new anti-cancer drugs a key driver in the pharmaceutical industry. Most cancer treatments are poorly
BACKGROUND Ai2 Limited is a University of Manchester spinout company that aims to become a significant player in the global anti-infectives market. The company’s focus is on developing novel anti-microbial products, for out-licensing to healthcare companies across a range of sectors. THE TECHNOLOGY
BACKGROUND 1 in 10 people are affected by peptic ulcers over the course of their lifetime. Incidence of the condition is set to increase as the population ages. Current treatment relies on combination antibiotic therapy. However, a 20% failure rate and increasing antibiotic resistance highlight the
BACKGROUND Heparan sulphate and heparin play a central role in a large number of processes including anti-coagulation, angiogenesis, cell growth and migration. A new class of medicinal drugs can be envisaged that would either promote or inhibit the function of heparan sulfate/heparin by mimicking or
BACKGROUND Opticin is a protein present in the eye (in the vitreous humour) and was discovered at University of Manchester by Dr Paul Bishop. Uniquely Opticin has been found to exhibit both cytotoxic AND anti-angiogenic (blood vessel formation) effects on a range of cell lines from different cancers
BACKGROUND Glucocorticoids (GCs) have been used therapeutically for many years to treat a range of inflammatory conditions as immunosuppressants and in the treatment of certain cancers. These compounds are the most potent and effective anti-inflammatory agents known. Their use has been limited howev
BACKGROUND Ai2 Limited is a University of Manchester spinout company that aims to become a significant player in the global anti-infectives market. The company’s focus is on developing novel anti-microbial products, for out-licensing to healthcare companies across a range of sectors. THE TECHNOLOGY
Swallowing problems after stroke are common, with over 40,000 patients annually in the UK suffering from dysphagia and its attendant consequences of aspiration pneumonia and malnutrition. This leads to longer hospital stays, increased demands on feeding resources, higher admissions to nursing homes
BACKGROUND A number of techniques are available for brain scanning and imaging including CT scanners, MRI, fMRI and PET. All require large expensive fixed installations and cannot be made available in all hospitals. Their imaging speed does not allow measuring brain activity or functional responses